U.S. Supreme Court justices divided over Teva patent battle
October 15, 2014 at 11:16 AM EDT
WASHINGTON, Oct 15 (Reuters) - The U.S. Supreme Court on Wednesday appeared closely divided as it weighed Teva Pharmaceutical Industries Ltd's high-profile fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug.